Nuwellis Reports Q4 Loss of $1.50 Per Share, Slightly Better Than Expected
NUWE sits 17% above its 52-week low of $1.195 on light trading volume (0.1× avg).
Summary
Nuwellis, Inc. announced a fourth-quarter loss of $1.50 per share. This actual reported loss is slightly better than the $1.56 per share loss that analysts had expected, as noted in a Reuters report on March 6th. Despite beating expectations, a loss of this magnitude is significant for a micro-cap company with a market capitalization of approximately $2.4 million and a stock price around $1.40. Traders will be evaluating the company's path to profitability and cash burn, especially following the recent lawsuit announcement on February 26th.
At the time of this announcement, NUWE was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $1.20 to $56.28. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.